We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU. The B ...
GSK PLC 24 June 2024 Issued: 24 June 2024, London UK GSK's Omjjara (momelotinib) approved in Japan for treatment of myelofibrosis · Omjjara approved for use in both newly diagnosed or...
GSK PLC 24 June 2024 Issued: 24 June 2024, London UK Jemperli (dostarlimab) plus chemotherapy application accepted for review by the European Medicines Agency to expand use to all patients...
GSK PLC 21 June 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Wendy Becker b) Position/status Independent...
GSK PLC 12 June 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...
GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in reg ...
GSK PLC 11 June 2024 Issued: 10 June 2024, London UK Statement: Zantac (ranitidine) litigation - GSK starts process for appeal of recent Delaware Daubert decision · Delaware Superior...
GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to ...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -8 | -0.49766718507 | 1607.5 | 1622.5 | 1575 | 10389487 | 1604.10195886 | DE |
4 | -130.5 | -7.54335260116 | 1730 | 1766.5 | 1575 | 10107150 | 1635.01489615 | DE |
12 | -62 | -3.73156786037 | 1661.5 | 1820 | 1575 | 7664206 | 1669.54654649 | DE |
26 | 149.7 | 10.3255621465 | 1449.8 | 1820 | 1445.6 | 8093407 | 1644.72276431 | DE |
52 | 167.3 | 11.6813294233 | 1432.2 | 1820 | 1302.6 | 7469284 | 1543.55465494 | DE |
156 | 189.3 | 13.4236278542 | 1410.2 | 1824.4 | 1283.2 | 8547975 | 1527.58633324 | DE |
260 | -1.9 | -0.118646184588 | 1601.4 | 1857 | 1190.8 | 8870098 | 1528.44689736 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions